Oncology & Cancer

Less-toxic chemo improves outlook for advanced bladder cancer

(Medical Xpress) -- New data from the University of Rochester Medical Center confirms that an easier, two-drug chemotherapy regimen given to bladder cancer patients prior to surgery shrinks locally advanced tumors and completely ...

Medications

Hair regrowth seen in alopecia with methotrexate + prednisone

For patients with recalcitrant alopecia areata totalis or universalis, methotrexate combined with prednisone yields complete hair regrowth in about 31 percent of patients, according to a study published online March 8 in ...

Diseases, Conditions, Syndromes

UVB preferred for treatment of moderate to severe psoriasis

(HealthDay) -- Ultraviolet B (UVB) is preferred by dermatologists for first-line treatment of moderate to severe psoriasis in both healthy male and female patients, according to a study published in the March issue of the ...

Diseases, Conditions, Syndromes

Study compares effectiveness of psoriasis treatments

(HealthDay) -- The effectiveness of therapies for psoriasis is variable, and may be lower in real-world settings than in trial settings, according to a study published in the April issue of the Archives of Dermatology.

Diseases, Conditions, Syndromes

Noninvasive test for NASH, fibrosis in patients with psoriasis

(HealthDay)—For patients with psoriasis receiving long-term methotrexate sodium therapy, a noninvasive test for nonalcoholic steatohepatitis (NASH) and hepatic fibrosis (NASH FibroSure) can be used to monitor development ...

Medications

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Diseases, Conditions, Syndromes

Methotrexate, azathioprine seem safe long-term for dermatitis

(HealthDay)—Methotrexate and azathioprine appear to be effective and safe as maintenance treatments in moderate-to-severe atopic dermatitis for up to five years, according to research published online Dec. 13 in the British ...

page 3 from 9